54 Member Networks and Programs Receive Commendations in 2024 for Research Performance

Lung x-ray on iPad
Trial Spotlight: Zofia Piotrowska on the EA5162 Trial for Patients with Advanced Non-Small Cell Lung Cancer
November 25, 2024
Fall 2024 Group Meeting Focuses on Real-World Data, Innovation, and Health Equity
November 25, 2024
Lung x-ray on iPad
Trial Spotlight: Zofia Piotrowska on the EA5162 Trial for Patients with Advanced Non-Small Cell Lung Cancer
November 25, 2024
Fall 2024 Group Meeting Focuses on Real-World Data, Innovation, and Health Equity
November 25, 2024

54 Member Networks and Programs Receive Commendations in 2024 for Research Performance

Evaluation Form

Each year, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) conducts an Institution Evaluation in which a subset of Principal Investigator (PI) Committee members and senior administrators meet to evaluate the performance of ECOG-ACRIN member networks and programs. The exceptional staff in the Membership Department facilitates the process—encompassing nearly 1500 individual research institutions in total, comprising 140 research programs. Through this annual review, principal investigators and research personnel stay informed about the many scientific and administrative components that comprise ECOG-ACRIN's expectations for retaining membership in the Group. In addition, the evaluation ensures that member institutions maintain ECOG-ACRIN's high standards for conducting cancer research with and through the Group.

Data from the previous calendar year (2023) was evaluated. The following areas are part of the review: accrual, clinical data quality and timeliness, compliance with requirements for submission of laboratory samples and images, scientific leadership, administrative contribution, and compliance with policies of both ECOG-ACRIN and the National Cancer Institute (NCI) through its National Clinical Trials Network (NCTN) audit process. The review committee is blinded to the identity of the institutions during this initial evaluation when they give a numerical rating to these categories. However, final unblinded assessments are based on objective data and discussions on the unique aspects of each institution that cannot be captured in a numerical rating.

For 2024, the review committee voted to commend the following 54 networks and NCI Community Oncology Research Programs (NCORPs). Group Co-Chairs Peter J. O'Dwyer, MD, and Mitchell D. Schnall, MD, PhD, recognized them during the Fall 2024 Group Meeting General Session.

Overall Outstanding Performance

Institution

Principal Investigator

Aultman Health System/Timken Family Cancer Center

Sunitha Vemulapalli, MD

Aurora NCORP

Thomas J. Saphner, MD

Carle Cancer Center NCORP

Kendrith M. Rowland, MD

Delaware/Christiana Care NCORP

Gregory A. Masters, MD

Duke University/Duke Cancer Institute

Daniel P. Barboriak, MD

Heartland Cancer Research NCORP

Bryan A. Faller, MD

Johns Hopkins University/The Sidney Kimmel Cancer Center

Julie R. Brahmer, MD

Mayo Clinic Cancer Center

Thomas M. Habermann, MD

Medical College of Wisconsin/MCW Cancer Center

Timothy S. Fenske, MD

Mount Sinai Health System/The Tisch Cancer Institute

Joseph A. Sparano, MD

New York University/NYU Langone Perlmutter Cancer Center

Catherine S. Diefenbach, MD

Northwestern University/Robert H. Lurie Comprehensive Cancer Center

Al B. Benson III, MD

The Ohio State University/The James Comprehensive Cancer Center

James W. Rocco, MD PhD

The University of Texas/MD Anderson Cancer Center

 In Transition

University of Massachusetts/UMass Cancer Center

Jan Cerny, MD, PhD

University of North Carolina at Chapel Hill/UNC Lineberger Comprehensive Cancer Center

Lisa A. Carey, MD

University of Pennsylvania/Abramson Cancer Center

Jennifer R. Eads, MD

University of Washington/Fred Hutchinson Cancer Center

Evan Y. Yu, MD

Vanderbilt University/Vanderbilt-Ingram Cancer Center

Kristen K. Ciombor, MD, MSCI

Yale University/Yale Cancer Center

Barbara A. Burtness, MD

 

Accrual, Scientific Contribution, and Administrative Participation

Institution

Principal Investigator

University of South Florida/Moffitt Cancer Center

Jhanelle E. Gray, MD

 

Accrual, Scientific Contribution, and Imaging Submission

Institution

Principal Investigator

University of Wisconsin/UW Carbone Cancer Center

Kari B. Wisinski, MD

 

Accrual and Scientific Contribution

Institution

Principal Investigator

Emory University/Winship Cancer Institute

Charles A. Staley III, MD

Memorial Sloan Kettering Cancer Center

In Transition

Accrual and Data Management

Institution

Principal Investigator

University of California San Francisco/Helen Diller Family Comprehensive Cancer Center

Thomas A. Hope, MD

Yonsei University Health System-Severance Hospital

Joohyuk Sohn, MD

 

Accrual

Institution

Principal Investigator

CERIM

Daniel E. Lehrer, MD

Gulf South Minority Underserved NCORP

Augusto C. Ochoa, MD

Hackensack University Medical Center

Donna M. McNamara, MD

Memorial Hermann Texas Medical Center

Syed H. Jafri, MD

National Cancer Center-Korea

Ji-Youn Han, MD

Allegheny General Hospital

Nathan Bahary, MD, PhD

Grupo de Estudios Clinicos Oncologicos del Peru

Carlos S. Vallejos Sologuren, MD

 

Scientific Contribution and Administrative Participation

Institution

Principal Investigator

Harvard University/Dana-Farber  Cancer Center

Frank S. Hodi, MD

National Capital Area Minority Underserved NCORP

Geoffrey T. Gibney, MD

Wisconsin NCORP

Kurt R. Oettel, MD

 

Scientific Contribution

Institution

Principal Investigator

Case Western Reserve University/Case Comprehensive Cancer Center

Paolo F. Caimi, MD

Fox Chase Cancer Center

Hossein Borghaei, DO

Indiana University/IU Melvin and Bren Simon Comprehensive Cancer Center

Kathy D. Miller, MD

Montefiore Minority Underserved NCORP

Balazs Halmos, MD

Rutgers Cancer Institute of New Jersey

Howard S. Hochster, MD

Stanford University/Stanford Cancer Institute

Melinda L. Telli, MD

Thomas Jefferson University/Sidney Kimmel Comprehensive Cancer Center

Steven J. Cohen, MD

Tufts University/Tufts Medical Center Cancer Center

Rachel J. Buchsbaum, MD

University of Michigan/UM Comprehensive Cancer Center

In Transition

University of Pittsburgh/UPMC Hillman Cancer Center

John M. Kirkwood, MD

The University of Texas Southwestern/Harold C. Simmons Comprehensive Cancer Center

David E. Gerber, MD

Washington University at St. Louis/Siteman Cancer Center

Barry A. Siegel, MD

 

Data Management, Laboratory Submission, and Imaging Submission

Institution

Principal Investigator

Penn State University/Penn State Cancer Institute 

Cristina I. Truica, MD

 

Data Management

Institution

Principal Investigator

Cancer Partners of Nebraska

Joni A. Tilford, MD

Essentia Health NCORP

Bret E. Friday, MD, PhD

Puerto Rico Minority Underserved NCORP

Luis J. Santos Reyes, MD

Upstate Carolina NCORP

James D. Bearden III, MD

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *